Published • loading... • Updated
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
The platform offers four times the throughput of Xenium and is priced at $495,000, with shipping expected in the second half of 2026.
- On Saturday, April 18, 2026, 10x Genomics, Inc. announced Atera at the AACR Annual Meeting 2026, a spatial biology platform engineered to deliver whole-transcriptome analysis with single-cell sensitivity at unprecedented scale.
- Michael Schnall-Levin, Chief Technology Officer, Chief Strategy Officer and Founding Scientist at 10x Genomics, said Atera reflects a first-principles approach, optimizing chemistry, hardware, and software to measure biological systems without previous constraints.
- Andrew Rech, Instructor of Pathology & Laboratory Medicine in the Carl June Lab at the Center for Cellular Immunotherapies at the University of Pennsylvania, said Atera enabled his team to "resolve rare immune cells" in glioblastoma patient samples.
- Poster #7116 demonstrates Atera's workflow for AI-driven biomarker discovery and early cancer detection, with the platform expected to begin shipping in the second half of 2026.
- Researchers at the German Cancer Research Institute and the Carl June Lab contributed early data to the launch, while Bioptimus plans to expand its spatial analysis programs to Atera in 2027 as throughput capacity increases.
Insights by Ground AI
30 Articles
30 Articles
10x Genomics Unveils Atera Spatial Platform at AACR Meeting
The genomics community’s long wait for 10x Genomics’ highly anticipated news is finally over. On Saturday night, at the Hard Rock Café Hotel in San Diego—across the street from the American Association for Cancer Research (AACR) conference—the company hosted the “Impossible” party to announce its new spatial instrument—the Atera. Serge Saxonov, PhD, CEO of 10x Genomics, walking onto the stage to thunderous applause, noted that there is “a gap be…
Coverage Details
Total News Sources30
Leaning Left0Leaning Right0Center16Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium








